MKS Instruments (MKSI) Financials

$87.45 +3.63 (+4.33%)

Closing price 04:00 PM Eastern

Extended Trading

$88.58 +1.13 (+1.29%)

As of 07:52 PM Eastern

Annual Income Statements for MKS Instruments

This table shows MKS Instruments' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	190	-1,841	333	551	350	140	393	339	105	122
Consolidated Net Income / (Loss)	190	-1,841	333	551	350	140	393	339	105	122
Net Income / (Loss) Continuing Operations	190	-1,841	333	551	350	140	393	339	105	122
Total Pre-Tax Income	180	-1,928	433	665	423	178	481	448	128	159
Total Operating Income	498	-1,554	617	699	454	220	494	407	157	157
Total Gross Profit	1,708	1,642	1,547	1,380	1,049	830	980	891	1,295	363
Total Revenue	3,586	3,622	3,547	2,950	2,330	1,900	2,075	1,916	1,295	814
Operating Revenue	3,586	3,622	3,547	2,950	2,330	1,900	2,075	1,916	1,295	814
Total Cost of Revenue	1,878	1,980	2,000	1,570	1,281	1,069	1,096	1,025	0.00	451
Operating Cost of Revenue	1,878	1,980	2,000	1,570	1,281	1,069	1,096	1,025	-	451
Total Operating Expenses	1,210	3,196	930	681	595	611	485	485	1,138	206
Selling, General & Admin Expense	674	675	488	385	353	330	298	290	228	129
Research & Development Expense	271	288	241	200	173	164	136	133	111	68
Amortization Expense	245	295	146	55	55	67	44	46	36	6.76
Other Operating Expenses / (Income)	5.00	2.00	0.00	0.00	-	6.60	0.40	0.49	731	-
Impairment Charge	0.00	1,902	0.00	0.00	-	4.70	0.00	6.72	5.00	-
Restructuring Charge	15	36	62	41	14	44	7.70	9.25	28	2.10
Other Special Charges / (Income)	0.00	-2.00	-7.00	0.00	0.00	-6.80	0.00	-	-	-
Total Other Income / (Expense), net	-318	-374	-184	-34	-31	-42	-13	41	-29	2.86
Interest Expense	341	364	177	25	29	44	17	31	31	0.14
Interest & Investment Income	21	17	4.00	0.00	1.00	5.40	5.80	3.02	2.56	3.00
Other Income / (Expense), net	2.00	-27	-11	-9.00	-3.00	-3.30	-2.00	69	-1.24	-
Income Tax Expense	-10	-87	100	114	73	37	88	108	23	37
Basic Earnings per Share	$2.82	($27.54)	$5.57	$9.95	$6.36	$2.57	$7.22	$6.26	$1.96	$2.30
Weighted Average Basic Shares Outstanding	67.30M	66.80M	59.70M	55.40M	55.10M	54.70M	54.41M	54.14M	53.47M	53.28M
Diluted Earnings per Share	$2.81	($27.54)	$5.56	$9.90	$6.33	$2.55	$7.14	$6.16	$1.94	$2.28
Weighted Average Diluted Shares Outstanding	67.60M	66.80M	59.90M	55.70M	55.30M	55.10M	55M	55.07M	54.05M	53.56M
Weighted Average Basic & Diluted Shares Outstanding	67.38M	67.06M	66.67M	55.52M	55.22M	54.87M	54.40M	54.20M	53.50M	53.20M
Cash Dividends to Common per Share	$0.88	$0.88	$0.88	$0.86	$0.80	$0.80	$0.78	$0.71	$0.68	$0.68

This table shows MKS Instruments' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	52	90	62	23	15	-69	39	-1,769	-42	54	6.00
Consolidated Net Income / (Loss)	52	90	62	23	15	-69	39	-1,769	-42	54	6.00
Net Income / (Loss) Continuing Operations	52	90	62	23	15	-69	39	-1,769	-42	54	6.00
Total Pre-Tax Income	59	79	60	22	19	-80	22	-1,791	-79	66	40
Total Operating Income	111	137	128	127	106	23	118	-1,696	1.00	163	118
Total Gross Profit	444	442	432	419	415	411	426	470	335	485	390
Total Revenue	936	935	896	887	868	893	932	1,003	794	1,086	954
Operating Revenue	936	935	896	887	868	893	932	1,003	794	1,086	954
Total Cost of Revenue	492	493	464	468	453	482	506	533	459	601	564
Operating Cost of Revenue	492	493	464	468	453	482	506	533	459	601	564
Total Operating Expenses	333	305	304	292	309	388	308	2,166	334	322	272
Selling, General & Admin Expense	185	176	167	161	170	162	167	172	174	169	126
Research & Development Expense	70	65	70	66	70	70	71	75	72	73	63
Amortization Expense	60	61	61	61	62	70	68	76	81	69	47
Other Operating Expenses / (Income)	2.00	-	2.00	0.00	3.00	2.00	0.00	0.00	0.00	-	-
Impairment Charge	0.00	-	0.00	0.00	0.00	75	0.00	1,827	0.00	-	0.00
Restructuring Charge	16	3.00	4.00	4.00	4.00	9.00	4.00	16	7.00	11	36
Other Special Charges / (Income)	0.00	-	0.00	0.00	0.00	-	-2.00	0.00	0.00	-	0.00
Total Other Income / (Expense), net	-52	-58	-68	-105	-87	-103	-96	-95	-80	-97	-78
Interest Expense	56	59	69	117	96	98	93	88	85	84	80
Interest & Investment Income	3.00	4.00	6.00	5.00	6.00	6.00	4.00	4.00	3.00	2.00	1.00
Other Income / (Expense), net	1.00	-3.00	-5.00	7.00	3.00	-11	-7.00	-11	2.00	-15	1.00
Income Tax Expense	7.00	-11	-2.00	-1.00	4.00	-11	-17	-22	-37	12	34
Basic Earnings per Share	$0.77	$1.34	$0.92	$0.34	$0.22	($1.02)	$0.59	($26.47)	($0.64)	$0.57	$0.09
Weighted Average Basic Shares Outstanding	67.40M	67.30M	67.40M	67.30M	67M	66.80M	66.90M	66.80M	66.70M	59.70M	61M
Diluted Earnings per Share	$0.77	$1.34	$0.92	$0.33	$0.22	($1.01)	$0.58	($26.47)	($0.64)	$0.58	$0.09
Weighted Average Diluted Shares Outstanding	67.70M	67.60M	67.60M	67.50M	67.40M	66.80M	67.10M	66.80M	66.70M	59.90M	61.10M
Weighted Average Basic & Diluted Shares Outstanding	67.07M	67.38M	67.30M	67.29M	67.20M	67.06M	66.88M	66.86M	66.77M	66.67M	66.51M
Cash Dividends to Common per Share	$0.22	-	$0.22	$0.22	$0.22	-	$0.22	$0.22	$0.22	-	$0.22

This table details how cash moves in and out of MKS Instruments' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-161	-34	-57	358	193	-230	309	100	6.34	-78
Net Cash From Operating Activities	528	319	529	640	513	245	414	355	180	138
Net Cash From Continuing Operating Activities	528	319	529	640	513	245	414	355	180	138
Net Income / (Loss) Continuing Operations	190	-1,841	333	551	350	140	393	339	105	122
Consolidated Net Income / (Loss)	190	-1,841	333	551	350	140	393	339	105	122
Depreciation Expense	348	397	216	104	99	110	80	83	66	22
Amortization Expense	30	33	108	2.00	3.00	15	4.70	11	24	-
Non-Cash Adjustments To Reconcile Net Income	169	2,031	62	57	58	72	54	11	46	26
Changes in Operating Assets and Liabilities, net	-209	-301	-190	-74	3.00	-93	-117	-88	-61	-32
Net Cash From Investing Activities	-117	-84	-4,552	-205	-202	-947	73	23	-727	-167
Net Cash From Continuing Investing Activities	-117	-84	-4,552	-205	-202	-947	73	23	-727	-167
Purchase of Property, Plant & Equipment	-118	-87	-164	-87	-85	-64	-63	-31	-19	-12
Acquisitions	0.00	0.00	-4,473	-268	0.00	-989	0.00	-	-940	-9.91
Purchase of Investments	0.00	0.00	-1.00	-497	-522	-246	-254	-230	-268	-386
Sale of Property, Plant & Equipment	1.00	3.00	9.00	0.00	0.00	42	0.00	-	-	-
Sale and/or Maturity of Investments	0.00	0.00	77	647	405	310	389	211	500	241
Net Cash From Financing Activities	-549	-259	3,971	-65	-122	476	-178	-280	560	-47
Net Cash From Continuing Financing Activities	-549	-259	3,971	-65	-122	476	-178	-280	560	-47
Repayment of Debt	-2,642	-415	-1,213	-15	-84	-112	-117	-258	-165	-
Payment of Dividends	-59	-59	-52	-47	-44	-44	-42	-38	-36	-36
Issuance of Debt	2,161	216	5,237	1.00	27	642	68	29	764	-
Other Financing Activities, net	-9.00	-1.00	-1.00	-4.00	-21	-11	-11	-12	-0.45	2.17
Effect of Exchange Rate Changes	-23	-	-5.00	-12	4.00	-	-	-	-	-1.69
Cash Interest Paid	268	305	110	23	26	40	15	20	21	0.03
Cash Income Taxes Paid	145	180	133	110	66	36	92	105	45	43

This table details how cash moves in and out of MKS Instruments' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-59	-147	11	5.00	-30	16	102	-123	-29	25	-181
Net Cash From Operating Activities	141	176	163	122	67	181	160	-59	37	184	199
Net Cash From Continuing Operating Activities	141	176	163	122	67	181	160	-59	37	184	199
Net Income / (Loss) Continuing Operations	52	91	62	22	15	-69	40	-1,770	-42	54	6.00
Consolidated Net Income / (Loss)	52	91	62	22	15	-69	40	-1,770	-42	54	6.00
Depreciation Expense	85	86	87	87	88	96	93	101	107	96	64
Amortization Expense	6.00	7.00	7.00	8.00	8.00	10	8.00	7.00	8.00	23	85
Non-Cash Adjustments To Reconcile Net Income	43	60	55	47	7.00	116	61	1,852	2.00	62	26
Changes in Operating Assets and Liabilities, net	-45	-68	-48	-42	-51	28	-42	-249	-38	-51	18
Net Cash From Investing Activities	-18	-51	-22	-26	-18	-34	-16	-17	-17	-52	-4,499
Net Cash From Continuing Investing Activities	-18	-51	-22	-26	-18	-34	-16	-17	-17	-52	-4,499
Purchase of Property, Plant & Equipment	-18	-51	-22	-27	-18	-34	-18	-18	-17	-55	-26
Net Cash From Financing Activities	-180	-246	-144	-87	-72	-143	-38	-35	-43	-137	4,139
Net Cash From Continuing Financing Activities	-180	-246	-144	-87	-72	-143	-38	-35	-43	-137	4,139
Repayment of Debt	-115	-234	-129	-1,470	-809	-347	-23	-21	-24	-378	-827
Repurchase of Common Equity	-45	-	-	-	-	-	-	-	-	-	-
Payment of Dividends	-15	-15	-14	-15	-15	-15	-15	-14	-15	-15	-13
Issuance of Debt	0.00	-	-	1,400	761	215	-	-1.00	2.00	252	4,979
Other Financing Activities, net	-5.00	3.00	-1.00	-2.00	-9.00	4.00	-	1.00	-6.00	4.00	-
Effect of Exchange Rate Changes	-2.00	-26	14	-4.00	-7.00	-	-4.00	-12	-6.00	30	-20

This table presents MKS Instruments' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	8,590	9,118	11,495	4,540	3,904	3,416	2,614	2,414	2,212	1,273
Total Current Assets	2,474	2,696	2,794	2,147	1,804	1,434	1,464	1,236	999	940
Cash & Equivalents	714	875	909	966	608	415	644	334	229	228
Accounts Receivable	615	603	720	443	393	341	295	300	249	102
Inventories, net	893	991	977	577	501	462	385	339	276	153
Other Current Assets	252	227	187	85	74	106	66	54	51	18
Plant, Property, & Equipment, net	771	784	800	326	284	242	194	172	175	69
Total Noncurrent Assets	5,345	5,638	7,901	2,067	1,815	1,741	956	1,006	1,039	265
Goodwill	2,479	2,554	4,308	1,228	1,066	1,059	587	591	589	200
Intangible Assets	2,272	2,619	3,173	576	512	565	320	366	408	44
Other Noncurrent Operating Assets	594	465	420	263	230	112	39	38	32	21
Total Liabilities & Shareholders' Equity	8,590	9,118	11,495	4,540	3,904	3,416	2,614	2,414	2,212	1,273
Total Liabilities	6,268	6,646	7,012	1,653	1,543	1,393	741	825	970	112
Total Current Liabilities	775	848	952	460	374	318	263	290	237	91
Short-Term Debt	50	93	93	9.00	15	12	3.99	2.97	11	-
Accounts Payable	341	327	426	168	111	88	84	83	69	23
Other Current Liabilities	384	428	433	89	81	79	63	61	52	28
Total Noncurrent Liabilities	5,493	5,798	6,060	1,193	1,169	1,075	478	535	733	21
Long-Term Debt	4,488	4,696	4,834	808	815	872	344	390	601	-
Noncurrent Deferred & Payable Income Tax Liabilities	504	640	783	99	59	72	48	62	66	2.66
Noncurrent Employee Benefit Liabilities	141	151	138	49	50	44	56	52	45	13
Other Noncurrent Operating Liabilities	360	311	305	237	245	87	30	32	21	5.43
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,322	2,472	4,483	2,887	2,361	2,023	1,873	1,589	1,242	1,161
Total Preferred & Common Equity	2,322	2,472	4,483	2,887	2,361	2,023	1,873	1,589	1,242	1,161
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,322	2,472	4,483	2,887	2,361	2,023	1,873	1,589	1,242	1,161
Common Stock	2,067	2,195	2,142	907	873	864	794	790	778	745
Retained Earnings	503	373	2,272	1,991	1,487	1,181	1,085	796	495	427
Accumulated Other Comprehensive Income / (Loss)	-248	-96	69	-11	0.30	-22	-5.66	3.45	-31	-11

This table presents MKS Instruments' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	8,556	9,023	8,863	8,931	9,140	9,230	11,366	11,372
Total Current Assets	2,426	2,668	2,648	2,661	2,775	2,728	2,748	2,791
Cash & Equivalents	655	861	850	845	859	757	880	884
Accounts Receivable	639	609	597	576	618	631	572	730
Inventories, net	894	940	938	971	1,009	1,036	1,058	961
Other Current Assets	238	258	262	268	288	303	237	215
Plant, Property, & Equipment, net	774	770	759	766	761	777	794	655
Total Noncurrent Assets	5,356	5,585	5,456	5,504	5,604	5,725	7,824	7,926
Goodwill	2,496	2,567	2,495	2,511	2,540	2,575	4,327	3,851
Intangible Assets	2,238	2,443	2,418	2,501	2,614	2,728	3,108	3,653
Other Noncurrent Operating Assets	622	575	543	492	450	422	389	422
Total Liabilities & Shareholders' Equity	8,556	9,023	8,863	8,931	9,140	9,230	11,366	11,372
Total Liabilities	6,202	6,625	6,630	6,507	6,664	6,735	6,915	7,223
Total Current Liabilities	781	781	740	721	838	835	876	1,011
Short-Term Debt	50	50	50	50	87	88	88	95
Accounts Payable	323	306	291	290	309	314	372	410
Other Current Liabilities	408	425	399	381	442	433	416	219
Total Noncurrent Liabilities	5,421	5,844	5,890	5,786	5,826	5,900	6,039	6,212
Long-Term Debt	4,409	4,758	4,832	4,692	4,787	4,819	4,837	4,893
Noncurrent Deferred & Payable Income Tax Liabilities	502	590	588	622	595	628	751	893
Noncurrent Employee Benefit Liabilities	139	154	144	148	139	143	138	131
Other Noncurrent Operating Liabilities	371	342	326	324	305	310	313	295
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,354	2,398	2,233	2,424	2,476	2,495	4,451	4,149
Total Preferred & Common Equity	2,354	2,398	2,233	2,424	2,476	2,495	4,451	4,149
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,354	2,398	2,233	2,424	2,476	2,495	4,451	4,149
Common Stock	2,067	2,053	2,042	2,201	2,180	2,168	2,154	2,124
Retained Earnings	512	428	381	373	455	431	2,215	2,233
Accumulated Other Comprehensive Income / (Loss)	-225	-83	-190	-150	-159	-104	82	-208

This table displays calculated financial ratios and metrics derived from MKS Instruments' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.99%	2.11%	20.24%	26.61%	22.64%	-8.45%	8.31%	47.91%	59.23%	4.18%
EBITDA Growth	176.28%	-223.76%	16.83%	43.94%	62.08%	-40.83%	1.36%	130.95%	37.82%	13.23%
EBIT Growth	131.63%	-360.89%	-12.17%	52.99%	108.31%	-56.00%	3.47%	204.81%	-0.37%	15.89%
NOPAT Growth	148.32%	-329.25%	-18.07%	54.18%	116.43%	-57.00%	31.01%	139.20%	7.24%	4.70%
Net Income Growth	110.32%	-652.85%	-39.56%	57.43%	149.29%	-64.27%	15.85%	223.57%	-14.30%	5.63%
EPS Growth	110.20%	-595.32%	-43.84%	56.40%	148.24%	-64.29%	15.91%	217.53%	-14.91%	5.56%
Operating Cash Flow Growth	65.52%	-39.70%	-17.34%	24.76%	109.82%	-40.91%	16.49%	97.24%	30.23%	35.70%
Free Cash Flow Firm Growth	-25.39%	119.13%	-2,123.41%	-34.56%	156.95%	-309.82%	12.62%	138.13%	-837.34%	3,273.89%
Invested Capital Growth	-3.76%	-24.87%	219.31%	13.38%	-1.24%	59.28%	4.53%	0.50%	182.66%	2.67%
Revenue Q/Q Growth	1.19%	-5.06%	9.98%	3.65%	37.44%	-18.63%	-2.41%	5.90%	21.90%	-3.63%
EBITDA Q/Q Growth	14.17%	-14.87%	6.04%	5.71%	16.27%	-5.67%	-4.64%	11.41%	48.19%	-8.50%
EBIT Q/Q Growth	32.28%	-9.41%	-5.90%	6.01%	22.89%	-12.31%	-4.75%	14.14%	33.41%	-9.45%
NOPAT Q/Q Growth	-7.27%	-9.90%	-5.27%	6.02%	22.61%	-11.56%	-2.56%	11.01%	31.70%	-7.02%
Net Income Q/Q Growth	512.90%	-7.16%	-22.56%	6.89%	26.22%	-17.04%	-1.50%	10.47%	23.53%	-6.62%
EPS Q/Q Growth	510.87%	-6.13%	-27.51%	6.45%	26.35%	-17.74%	-1.24%	10.20%	23.57%	-6.56%
Operating Cash Flow Q/Q Growth	-0.94%	-0.93%	-2.04%	8.11%	15.75%	-19.25%	15.23%	8.58%	5.88%	6.56%
Free Cash Flow Firm Q/Q Growth	7.56%	32.89%	-5.38%	21.27%	16.70%	-9.63%	18.12%	0.20%	2.96%	3.23%
Invested Capital Q/Q Growth	-3.14%	-1.60%	3.01%	0.03%	0.61%	0.13%	-2.41%	1.84%	-0.29%	-2.17%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	47.63%	45.33%	43.61%	46.78%	45.02%	43.71%	47.20%	46.53%	100.00%	44.61%
EBITDA Margin	24.48%	-31.78%	26.22%	26.98%	23.73%	17.96%	27.79%	29.69%	19.02%	21.97%
Operating Margin	13.89%	-42.90%	17.40%	23.69%	19.49%	11.57%	23.81%	21.22%	12.14%	19.25%
EBIT Margin	13.94%	-43.65%	17.08%	23.39%	19.36%	11.40%	23.71%	24.82%	12.05%	19.25%
Profit (Net Income) Margin	5.30%	-50.83%	9.39%	18.68%	15.02%	7.39%	18.93%	17.70%	8.09%	15.03%
Tax Burden Percent	105.56%	95.49%	76.91%	82.86%	82.74%	78.97%	81.68%	75.76%	81.90%	76.69%
Interest Burden Percent	36.00%	121.95%	71.45%	96.38%	93.79%	82.12%	97.74%	94.12%	82.02%	101.82%
Effective Tax Rate	-5.56%	0.00%	23.09%	17.14%	17.26%	21.03%	18.32%	24.24%	18.10%	23.31%
Return on Invested Capital (ROIC)	8.39%	-14.62%	8.50%	23.12%	15.90%	8.97%	27.64%	21.63%	13.39%	24.21%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.29%	-33.61%	1.04%	46.79%	0.86%	258.02%	31.59%	367.08%	23.40%	23.86%
Return on Net Nonoperating Assets (RNNOA)	-0.46%	-38.33%	0.53%	-2.12%	0.07%	-1.76%	-4.94%	2.33%	-4.67%	-13.30%
Return on Equity (ROE)	7.93%	-52.94%	9.04%	21.00%	15.97%	7.21%	22.70%	23.96%	8.72%	10.91%
Cash Return on Invested Capital (CROIC)	12.22%	13.79%	-96.10%	10.58%	17.14%	-36.75%	23.21%	21.13%	-82.08%	21.58%
Operating Return on Assets (OROA)	5.65%	-15.34%	7.56%	16.34%	12.32%	7.18%	19.57%	20.56%	8.95%	12.54%
Return on Assets (ROA)	2.15%	-17.86%	4.15%	13.05%	9.56%	4.66%	15.63%	14.66%	6.01%	9.79%
Return on Common Equity (ROCE)	7.93%	-52.94%	9.04%	21.00%	15.97%	7.21%	22.70%	23.96%	8.72%	10.91%
Return on Equity Simple (ROE_SIMPLE)	8.18%	-74.47%	7.43%	19.09%	14.82%	6.94%	20.97%	21.34%	8.44%	10.53%
Net Operating Profit after Tax (NOPAT)	526	-1,088	475	579	376	174	404	308	129	120
NOPAT Margin	14.66%	-30.03%	13.38%	19.63%	16.12%	9.14%	19.45%	16.08%	9.94%	14.76%
Net Nonoperating Expense Percent (NNEP)	8.68%	18.99%	7.46%	-23.67%	15.04%	-249.05%	-3.95%	-345.45%	-10.01%	0.35%
Return On Investment Capital (ROIC_SIMPLE)	7.66%	-14.98%	5.04%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	52.37%	54.67%	56.39%	53.22%	54.98%	56.29%	52.80%	53.47%	0.00%	55.40%
SG&A Expenses to Revenue	18.80%	18.64%	13.76%	13.05%	15.15%	17.39%	14.37%	15.14%	17.60%	15.87%
R&D to Revenue	7.56%	7.95%	6.79%	6.78%	7.42%	8.64%	6.54%	6.92%	8.54%	8.40%
Operating Expenses to Revenue	33.74%	88.24%	26.22%	23.08%	25.54%	32.14%	23.39%	25.30%	87.86%	25.35%
Earnings before Interest and Taxes (EBIT)	500	-1,581	606	690	451	217	492	476	156	157
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	878	-1,151	930	796	553	341	577	569	246	179
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.02	2.76	1.23	3.28	3.42	2.87	1.78	3.07	2.41	1.53
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	8.73	10.33	14.49	3.46	7.72	12.23	1.94
Price to Revenue (P/Rev)	1.95	1.88	1.56	3.21	3.47	3.05	1.61	2.54	2.31	2.18
Price to Earnings (P/E)	36.90	0.00	16.60	17.16	23.08	41.31	8.50	14.37	28.61	14.53
Dividend Yield	0.84%	0.86%	1.06%	0.50%	0.55%	0.75%	1.26%	0.79%	1.22%	2.02%
Earnings Yield	2.71%	0.00%	6.02%	5.83%	4.33%	2.42%	11.76%	6.96%	3.50%	6.88%
Enterprise Value to Invested Capital (EV/IC)	1.76	1.68	1.12	3.47	3.43	2.59	1.98	3.30	2.24	2.23
Enterprise Value to Revenue (EV/Rev)	3.02	2.96	2.69	3.13	3.46	3.24	1.43	2.46	2.45	1.38
Enterprise Value to EBITDA (EV/EBITDA)	12.34	0.00	10.26	11.60	14.58	18.04	5.14	8.29	12.90	6.26
Enterprise Value to EBIT (EV/EBIT)	21.67	0.00	15.75	13.38	17.88	28.42	6.02	9.91	20.36	7.14
Enterprise Value to NOPAT (EV/NOPAT)	20.61	0.00	20.11	15.94	21.47	35.45	7.34	15.30	24.67	9.31
Enterprise Value to Operating Cash Flow (EV/OCF)	20.52	33.64	18.04	14.42	15.72	25.17	7.16	13.27	17.64	8.09
Enterprise Value to Free Cash Flow (EV/FCFF)	14.15	10.46	0.00	34.82	19.91	0.00	8.74	15.66	0.00	10.45
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.95	1.94	1.10	0.28	0.35	0.44	0.19	0.25	0.49	0.00
Long-Term Debt to Equity	1.93	1.90	1.08	0.28	0.35	0.43	0.18	0.25	0.48	0.00
Financial Leverage	1.61	1.14	0.51	-0.05	0.08	-0.01	-0.16	0.01	-0.20	-0.56
Leverage Ratio	3.69	2.96	2.18	1.61	1.67	1.55	1.45	1.63	1.45	1.11
Compound Leverage Factor	1.33	3.61	1.55	1.55	1.57	1.27	1.42	1.54	1.19	1.13
Debt to Total Capital	66.15%	65.96%	52.36%	22.06%	26.00%	30.40%	15.66%	19.83%	33.02%	0.00%
Short-Term Debt to Total Capital	0.73%	1.28%	0.99%	0.24%	0.45%	0.42%	0.18%	0.15%	0.59%	0.00%
Long-Term Debt to Total Capital	65.42%	64.67%	51.37%	21.81%	25.55%	29.99%	15.48%	19.68%	32.43%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	33.85%	34.04%	47.64%	77.94%	74.00%	69.60%	84.34%	80.17%	66.98%	100.00%
Debt to EBITDA	5.17	-4.16	5.30	1.03	1.50	2.59	0.60	0.69	2.49	0.00
Net Debt to EBITDA	4.36	-3.40	4.32	-0.28	-0.02	1.04	-0.66	-0.28	0.73	0.00
Long-Term Debt to EBITDA	5.11	-4.08	5.20	1.02	1.47	2.55	0.60	0.69	2.44	0.00
Debt to NOPAT	8.63	-4.40	10.38	1.41	2.21	5.09	0.86	1.28	4.75	0.00
Net Debt to NOPAT	7.27	-3.60	8.47	-0.39	-0.03	2.04	-0.94	-0.52	1.39	0.00
Long-Term Debt to NOPAT	8.54	-4.32	10.19	1.40	2.17	5.02	0.85	1.27	4.67	0.00
Altman Z-Score	1.60	0.74	1.42	5.64	5.09	4.14	5.25	5.92	3.40	11.79
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.19	3.18	2.93	4.67	4.83	4.51	5.56	4.27	4.21	10.33
Quick Ratio	1.71	1.74	1.71	3.23	3.29	2.72	3.85	2.91	2.81	8.35
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	766	1,026	-5,363	265	405	-711	339	301	-789	107
Operating Cash Flow to CapEx	451.28%	379.76%	341.29%	735.63%	603.53%	1,121.56%	657.87%	1,135.37%	941.79%	1,114.02%
Free Cash Flow to Firm to Interest Expense	2.25	2.82	-30.30	10.60	13.97	-16.13	20.06	9.71	-25.79	748.62
Operating Cash Flow to Interest Expense	1.55	0.88	2.99	25.60	17.69	5.54	24.49	11.46	5.88	967.10
Operating Cash Flow Less CapEx to Interest Expense	1.21	0.65	2.11	22.12	14.76	5.05	20.76	10.45	5.26	880.29
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.41	0.35	0.44	0.70	0.64	0.63	0.83	0.83	0.74	0.65
Accounts Receivable Turnover	5.89	5.48	6.10	7.06	6.35	5.97	6.97	6.98	7.39	7.81
Inventory Turnover	1.99	2.01	2.57	2.91	2.66	2.53	3.03	3.33	0.00	2.93
Fixed Asset Turnover	4.61	4.57	6.30	9.67	8.86	8.71	11.33	11.06	10.64	11.49
Accounts Payable Turnover	5.62	5.26	6.73	11.27	12.87	12.42	13.17	13.49	0.00	15.72
Days Sales Outstanding (DSO)	61.99	66.66	59.84	51.70	57.48	61.15	52.40	52.30	49.40	46.72
Days Inventory Outstanding (DIO)	183.08	181.39	141.80	125.36	137.27	144.51	120.56	109.54	0.00	124.65
Days Payable Outstanding (DPO)	64.91	69.41	54.20	32.39	28.35	29.39	27.71	27.05	0.00	23.22
Cash Conversion Cycle (CCC)	180.16	178.65	147.44	144.67	166.39	176.27	145.25	134.79	49.40	148.14
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	6,146	6,386	8,500	2,662	2,348	2,377	1,493	1,428	1,421	503
Invested Capital Turnover	0.57	0.49	0.64	1.18	0.99	0.98	1.42	1.35	1.35	1.64
Increase / (Decrease) in Invested Capital	-240	-2,114	5,838	314	-29	885	65	7.11	918	13
Enterprise Value (EV)	10,834	10,730	9,545	9,231	8,065	6,154	2,961	4,713	3,177	1,119
Market Capitalization	7,010	6,816	5,528	9,456	8,078	5,800	3,342	4,874	2,998	1,777
Book Value per Share	$34.50	$36.96	$67.41	$52.06	$42.82	$37.12	$34.70	$29.26	$23.17	$21.80
Tangible Book Value per Share	($36.09)	($40.39)	($45.08)	$19.53	$14.19	$7.34	$17.90	$11.63	$4.58	$17.22
Total Capital	6,860	7,261	9,410	3,704	3,190	2,907	2,221	1,982	1,854	1,161
Total Debt	4,538	4,789	4,927	817	830	884	348	393	612	0.00
Total Long-Term Debt	4,488	4,696	4,834	808	815	872	344	390	601	0.00
Net Debt	3,824	3,914	4,017	-225	-13	354	-381	-161	179	-658
Capital Expenditures (CapEx)	117	84	155	87	85	22	63	31	19	12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,035	1,066	1,025	654	609	604	487	406	349	190
Debt-free Net Working Capital (DFNWC)	1,749	1,941	1,935	1,696	1,445	1,128	1,205	949	772	849
Net Working Capital (NWC)	1,699	1,848	1,842	1,687	1,431	1,116	1,201	946	761	849
Net Nonoperating Expense (NNE)	336	753	142	28	26	33	11	-31	24	-2.19
Net Nonoperating Obligations (NNO)	3,824	3,914	4,017	-225	-13	354	-381	-161	179	-658
Total Depreciation and Amortization (D&A)	378	430	324	106	102	125	85	93	90	22
Debt-free, Cash-free Net Working Capital to Revenue	28.86%	29.43%	28.90%	22.17%	26.14%	31.79%	23.45%	21.19%	26.95%	23.39%
Debt-free Net Working Capital to Revenue	48.77%	53.59%	54.55%	57.49%	62.02%	59.37%	58.06%	49.55%	59.63%	104.30%
Net Working Capital to Revenue	47.38%	51.02%	51.93%	57.19%	61.39%	58.73%	57.87%	49.40%	58.79%	104.30%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.82	($27.54)	$5.57	$9.95	$6.36	$2.57	$7.22	$6.26	$1.96	$2.30
Adjusted Weighted Average Basic Shares Outstanding	67.30M	66.80M	59.70M	55.40M	55.10M	54.71M	54.41M	54.14M	53.47M	53.28M
Adjusted Diluted Earnings per Share	$2.81	($27.54)	$5.56	$9.90	$6.33	$2.55	$7.14	$6.16	$1.94	$2.28
Adjusted Weighted Average Diluted Shares Outstanding	67.60M	66.80M	59.90M	55.70M	55.30M	55.11M	54.99M	55.07M	54.05M	53.56M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	67.38M	67.06M	66.67M	55.52M	55.22M	54.87M	54.20M	54.49M	53.82M	53.24M
Normalized Net Operating Profit after Tax (NOPAT)	359	267	517	613	387	207	410	320	156	122
Normalized NOPAT Margin	10.01%	7.38%	14.57%	20.78%	16.62%	10.89%	19.75%	16.71%	12.02%	14.96%
Pre Tax Income Margin	5.02%	-53.23%	12.21%	22.54%	18.15%	9.36%	23.18%	23.36%	9.88%	19.60%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.47	-4.34	3.42	27.60	15.55	4.91	29.12	15.35	5.10	1,095.19
NOPAT to Interest Expense	1.54	-2.99	2.68	23.17	12.95	3.94	23.88	9.94	4.21	839.91
EBIT Less CapEx to Interest Expense	1.12	-4.57	2.55	24.12	12.62	4.42	25.40	14.34	4.47	1,008.38
NOPAT Less CapEx to Interest Expense	1.20	-3.22	1.81	19.69	10.02	3.44	20.16	8.93	3.58	753.10
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	31.05%	-3.20%	15.62%	8.53%	12.57%	30.98%	10.79%	11.26%	34.69%	29.41%
Augmented Payout Ratio	31.05%	-3.20%	15.62%	8.53%	12.57%	30.98%	29.88%	11.26%	36.17%	40.28%

This table displays calculated financial ratios and metrics derived from MKS Instruments' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	7.83%	4.70%	-3.86%	-11.57%	9.32%	-17.77%	-2.31%	31.11%	7.01%	42.15%	28.57%
EBITDA Growth	-0.98%	92.37%	2.36%	114.32%	73.73%	-55.81%	-20.90%	-941.58%	-42.44%	24.77%	34.67%
EBIT Growth	2.75%	1,016.67%	10.81%	107.85%	3,533.33%	-91.89%	-6.72%	-1,153.70%	-98.31%	-20.43%	-30.81%
NOPAT Growth	16.90%	869.42%	-36.77%	111.18%	11,854.89%	-87.93%	1,081.82%	-968.68%	-99.51%	-13.14%	-87.28%
Net Income Growth	246.67%	230.43%	58.97%	101.30%	135.71%	-227.78%	550.00%	-1,460.77%	-129.37%	-64.24%	-95.45%
EPS Growth	250.00%	232.67%	58.62%	101.25%	134.38%	-274.14%	544.44%	-1,240.95%	-124.90%	-78.44%	-96.22%
Operating Cash Flow Growth	110.45%	-2.76%	1.88%	306.78%	81.08%	-1.63%	-19.60%	-156.19%	-9.76%	-5.64%	30.07%
Free Cash Flow Firm Growth	-88.50%	-81.41%	-85.93%	110.35%	139.61%	137.34%	135.37%	-1,312.93%	-1,992.10%	-3,452.76%	-2,855.82%
Invested Capital Growth	-2.56%	-3.76%	-2.23%	-5.72%	-25.60%	-24.87%	-21.35%	130.94%	204.26%	219.31%	210.07%
Revenue Q/Q Growth	0.11%	4.35%	1.01%	2.19%	-2.80%	-4.18%	-7.08%	26.32%	-26.89%	13.84%	24.71%
EBITDA Q/Q Growth	-10.57%	4.61%	-5.24%	11.71%	73.73%	-44.34%	113.26%	-1,455.08%	-55.81%	-0.37%	41.05%
EBIT Q/Q Growth	-16.42%	8.94%	-8.21%	22.94%	808.33%	-89.19%	106.50%	-57,000.00%	-97.97%	24.37%	-26.54%
NOPAT Q/Q Growth	-37.32%	18.00%	-0.38%	58.66%	419.78%	-92.30%	117.62%	-169,700.00%	-99.48%	653.47%	-87.05%
Net Income Q/Q Growth	-42.22%	45.16%	169.57%	53.33%	121.74%	-276.92%	102.20%	-4,111.90%	-177.78%	800.00%	-95.38%
EPS Q/Q Growth	-42.54%	45.65%	178.79%	50.00%	121.78%	-274.14%	102.19%	-4,035.94%	-210.34%	544.44%	-96.12%
Operating Cash Flow Q/Q Growth	-19.89%	7.98%	33.61%	82.09%	-62.98%	13.13%	371.19%	-259.46%	-79.89%	-7.54%	89.52%
Free Cash Flow Firm Q/Q Growth	-34.40%	42.85%	-45.93%	-77.30%	6.04%	8.06%	139.79%	13.12%	0.04%	-2.36%	-1,489.41%
Invested Capital Q/Q Growth	0.20%	-3.14%	1.29%	-0.89%	-1.03%	-1.60%	-2.32%	-21.79%	-0.06%	3.01%	186.83%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	47.44%	47.27%	48.21%	47.24%	47.81%	46.02%	45.71%	46.86%	42.19%	44.66%	40.88%
EBITDA Margin	21.69%	24.28%	24.22%	25.82%	23.62%	13.21%	22.75%	-159.42%	14.86%	24.59%	28.09%
Operating Margin	11.86%	14.65%	14.29%	14.32%	12.21%	2.58%	12.66%	-169.09%	0.13%	15.01%	12.37%
EBIT Margin	11.97%	14.33%	13.73%	15.11%	12.56%	1.34%	11.91%	-170.19%	0.38%	13.63%	12.47%
Profit (Net Income) Margin	5.56%	9.63%	6.92%	2.59%	1.73%	-7.73%	4.18%	-176.37%	-5.29%	4.97%	0.63%
Tax Burden Percent	88.14%	113.92%	103.33%	104.55%	78.95%	86.25%	177.27%	98.77%	53.16%	81.82%	15.00%
Interest Burden Percent	52.68%	58.96%	48.78%	16.42%	17.43%	-666.67%	19.82%	104.92%	-2,633.33%	44.59%	33.61%
Effective Tax Rate	11.86%	-13.92%	-3.33%	-4.55%	21.05%	0.00%	-77.27%	0.00%	0.00%	18.18%	85.00%
Return on Invested Capital (ROIC)	6.12%	9.55%	8.15%	8.30%	4.81%	0.88%	11.62%	-95.40%	0.06%	7.80%	1.10%
ROIC Less NNEP Spread (ROIC-NNEP)	4.93%	7.85%	6.39%	5.62%	3.08%	-1.27%	7.42%	-125.26%	-2.19%	3.62%	0.51%
Return on Net Nonoperating Assets (RNNOA)	7.95%	12.66%	10.43%	9.72%	3.56%	-1.45%	9.10%	-86.80%	-1.11%	1.86%	0.30%
Return on Equity (ROE)	14.07%	22.22%	18.58%	18.02%	8.37%	-0.57%	20.71%	-182.20%	-1.06%	9.67%	1.39%
Cash Return on Invested Capital (CROIC)	10.92%	12.22%	11.09%	9.94%	15.67%	13.79%	10.48%	-99.92%	-94.66%	-96.10%	-93.28%
Operating Return on Assets (OROA)	5.00%	5.80%	5.36%	5.98%	4.57%	0.47%	4.43%	-93.43%	0.17%	6.03%	5.11%
Return on Assets (ROA)	2.32%	3.90%	2.70%	1.03%	0.63%	-2.72%	1.56%	-96.82%	-2.38%	2.20%	0.26%
Return on Common Equity (ROCE)	14.07%	22.22%	18.58%	18.02%	8.37%	-0.57%	20.71%	-182.20%	-1.06%	9.67%	1.39%
Return on Equity Simple (ROE_SIMPLE)	9.64%	0.00%	1.29%	0.36%	-73.60%	0.00%	-69.39%	-70.18%	3.33%	0.00%	10.36%
Net Operating Profit after Tax (NOPAT)	98	156	132	133	84	16	209	-1,187	0.70	133	18
NOPAT Margin	10.45%	16.69%	14.76%	14.97%	9.64%	1.80%	22.44%	-118.36%	0.09%	12.28%	1.86%
Net Nonoperating Expense Percent (NNEP)	1.19%	1.71%	1.77%	2.68%	1.73%	2.15%	4.19%	29.86%	2.24%	4.19%	0.58%
Return On Investment Capital (ROIC_SIMPLE)	1.44%	2.28%	-	-	-	0.22%	-	-	-	1.42%	-
Cost of Revenue to Revenue	52.56%	52.73%	51.79%	52.76%	52.19%	53.98%	54.29%	53.14%	57.81%	55.34%	59.12%
SG&A Expenses to Revenue	19.77%	18.82%	18.64%	18.15%	19.59%	18.14%	17.92%	17.15%	21.91%	15.56%	13.21%
R&D to Revenue	7.48%	6.95%	7.81%	7.44%	8.06%	7.84%	7.62%	7.48%	9.07%	6.72%	6.60%
Operating Expenses to Revenue	35.58%	32.62%	33.93%	32.92%	35.60%	43.45%	33.05%	215.95%	42.07%	29.65%	28.51%
Earnings before Interest and Taxes (EBIT)	112	134	123	134	109	12	111	-1,707	3.00	148	119
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	203	227	217	229	205	118	212	-1,599	118	267	268
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.29	3.02	3.05	3.93	3.66	2.76	2.32	2.87	1.31	1.23	1.09
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.48	1.95	2.06	2.45	2.40	1.88	1.50	1.86	1.62	1.56	1.41
Price to Earnings (P/E)	23.79	36.90	235.96	1,096.82	0.00	0.00	0.00	0.00	39.48	16.60	10.54
Dividend Yield	1.10%	0.84%	0.81%	0.67%	0.66%	0.86%	1.03%	0.82%	1.00%	1.06%	1.35%
Earnings Yield	4.20%	2.71%	0.42%	0.09%	0.00%	0.00%	0.00%	0.00%	2.53%	6.02%	9.49%
Enterprise Value to Invested Capital (EV/IC)	1.49	1.76	1.77	2.04	2.02	1.68	1.50	1.70	1.16	1.12	1.05
Enterprise Value to Revenue (EV/Rev)	2.52	3.02	3.18	3.58	3.46	2.96	2.56	2.95	2.75	2.69	2.68
Enterprise Value to EBITDA (EV/EBITDA)	10.51	12.34	14.64	16.76	0.00	0.00	0.00	0.00	11.73	10.26	9.85
Enterprise Value to EBIT (EV/EBIT)	18.30	21.67	29.79	34.99	0.00	0.00	0.00	0.00	22.89	15.75	13.41
Enterprise Value to NOPAT (EV/NOPAT)	17.73	20.61	19.87	48.91	0.00	0.00	0.00	0.00	27.41	20.11	17.24
Enterprise Value to Operating Cash Flow (EV/OCF)	15.29	20.52	21.13	24.16	36.61	33.64	30.29	31.31	18.83	18.04	15.99
Enterprise Value to Free Cash Flow (EV/FCFF)	13.52	14.15	15.82	19.95	11.01	10.46	12.63	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.89	1.95	2.01	2.19	1.96	1.94	1.97	1.97	1.11	1.10	1.20
Long-Term Debt to Equity	1.87	1.93	1.98	2.16	1.94	1.90	1.93	1.93	1.09	1.08	1.18
Financial Leverage	1.61	1.61	1.63	1.73	1.15	1.14	1.23	0.69	0.51	0.51	0.58
Leverage Ratio	3.66	3.69	3.73	3.83	2.95	2.96	3.10	2.49	2.14	2.18	2.28
Compound Leverage Factor	1.93	2.18	1.82	0.63	0.51	-19.76	0.61	2.61	-56.40	0.97	0.77
Debt to Total Capital	65.45%	66.15%	66.72%	68.62%	66.17%	65.96%	66.31%	66.29%	52.53%	52.36%	54.59%
Short-Term Debt to Total Capital	0.73%	0.73%	0.69%	0.70%	0.70%	1.28%	1.18%	1.19%	0.94%	0.99%	1.04%
Long-Term Debt to Total Capital	64.71%	65.42%	66.03%	67.91%	65.48%	64.67%	65.13%	65.10%	51.59%	51.37%	53.55%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	34.55%	33.85%	33.28%	31.38%	33.83%	34.04%	33.69%	33.71%	47.47%	47.64%	45.41%
Debt to EBITDA	5.09	5.17	6.25	6.39	-4.46	-4.16	-4.86	-5.19	5.84	5.30	5.69
Net Debt to EBITDA	4.34	4.36	5.13	5.28	-3.66	-3.40	-4.01	-4.39	4.80	4.32	4.68
Long-Term Debt to EBITDA	5.03	5.11	6.19	6.32	-4.41	-4.08	-4.78	-5.09	5.74	5.20	5.58
Debt to NOPAT	8.59	8.63	8.48	18.65	-4.68	-4.40	-4.92	-4.96	13.65	10.38	9.96
Net Debt to NOPAT	7.33	7.27	6.96	15.40	-3.84	-3.60	-4.06	-4.19	11.21	8.47	8.19
Long-Term Debt to NOPAT	8.50	8.54	8.39	18.46	-4.63	-4.32	-4.84	-4.87	13.41	10.19	9.77
Altman Z-Score	1.31	1.46	1.42	1.57	1.59	1.32	1.30	0.75	1.30	1.29	1.16
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.11	3.19	3.42	3.58	3.69	3.18	3.31	3.27	3.14	2.93	2.76
Quick Ratio	1.66	1.71	1.88	1.96	1.97	1.74	1.76	1.66	1.66	1.71	1.60
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	260	396	277	513	2,259	2,130	1,971	-4,954	-5,702	-5,705	-5,573
Operating Cash Flow to CapEx	783.33%	345.10%	740.91%	469.23%	372.22%	532.35%	1,000.00%	-347.06%	217.65%	347.17%	765.38%
Free Cash Flow to Firm to Interest Expense	4.64	6.71	4.02	4.38	23.53	21.74	21.20	-56.30	-67.09	-67.91	-69.66
Operating Cash Flow to Interest Expense	2.52	2.98	2.36	1.04	0.70	1.85	1.72	-0.67	0.44	2.19	2.49
Operating Cash Flow Less CapEx to Interest Expense	2.20	2.12	2.04	0.82	0.51	1.50	1.55	-0.86	0.24	1.56	2.16
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.42	0.41	0.39	0.40	0.36	0.35	0.37	0.55	0.45	0.44	0.41
Accounts Receivable Turnover	6.01	5.89	5.78	5.83	6.44	5.48	5.66	6.90	6.84	6.10	5.50
Inventory Turnover	2.06	1.99	1.92	1.93	1.95	2.01	2.13	2.50	2.42	2.57	2.39
Fixed Asset Turnover	4.75	4.61	4.63	4.66	4.74	4.57	5.39	6.65	6.40	6.30	6.64
Accounts Payable Turnover	6.25	5.62	6.07	6.31	5.96	5.26	5.84	8.72	7.53	6.73	6.45
Days Sales Outstanding (DSO)	60.68	61.99	63.19	62.60	56.69	66.66	64.48	52.89	53.35	59.84	66.40
Days Inventory Outstanding (DIO)	177.55	183.08	190.52	188.71	187.58	181.39	171.28	145.95	150.73	141.80	152.56
Days Payable Outstanding (DPO)	58.36	64.91	60.12	57.84	61.20	69.41	62.51	41.88	48.49	54.20	56.61
Cash Conversion Cycle (CCC)	179.87	180.16	193.58	193.48	183.07	178.65	173.25	156.96	155.58	147.44	162.36
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	6,158	6,146	6,345	6,264	6,320	6,386	6,490	6,644	8,495	8,500	8,252
Invested Capital Turnover	0.59	0.57	0.55	0.55	0.50	0.49	0.52	0.81	0.64	0.64	0.59
Increase / (Decrease) in Invested Capital	-162	-240	-145	-380	-2,175	-2,114	-1,762	3,767	5,703	5,838	5,591
Enterprise Value (EV)	9,204	10,834	11,262	12,806	12,776	10,730	9,753	11,304	9,887	9,545	8,636
Market Capitalization	5,400	7,010	7,315	8,775	8,880	6,816	5,739	7,155	5,843	5,528	4,533
Book Value per Share	$34.94	$34.50	$35.64	$33.23	$36.18	$36.96	$37.03	$37.37	$66.76	$67.41	$74.43
Tangible Book Value per Share	($35.32)	($36.09)	($38.82)	($39.88)	($38.63)	($40.39)	($40.05)	($42.06)	($44.76)	($45.08)	($60.19)
Total Capital	6,813	6,860	7,206	7,115	7,166	7,261	7,350	7,402	9,376	9,410	9,137
Total Debt	4,459	4,538	4,808	4,882	4,742	4,789	4,874	4,907	4,925	4,927	4,988
Total Long-Term Debt	4,409	4,488	4,758	4,832	4,692	4,696	4,787	4,819	4,837	4,834	4,893
Net Debt	3,804	3,824	3,947	4,031	3,896	3,914	4,014	4,149	4,044	4,017	4,103
Capital Expenditures (CapEx)	18	51	22	26	18	34	16	17	17	53	26
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,040	1,035	1,076	1,107	1,144	1,066	1,164	1,223	1,079	1,025	990
Debt-free Net Working Capital (DFNWC)	1,695	1,749	1,937	1,958	1,990	1,941	2,024	1,981	1,960	1,935	1,875
Net Working Capital (NWC)	1,645	1,699	1,887	1,908	1,940	1,848	1,937	1,893	1,872	1,842	1,780
Net Nonoperating Expense (NNE)	46	66	70	110	69	85	170	582	43	79	12
Net Nonoperating Obligations (NNO)	3,804	3,824	3,947	4,031	3,896	3,914	4,014	4,149	4,044	4,017	4,103
Total Depreciation and Amortization (D&A)	91	93	94	95	96	106	101	108	115	119	149
Debt-free, Cash-free Net Working Capital to Revenue	28.46%	28.86%	30.36%	30.92%	30.95%	29.43%	30.51%	31.87%	29.98%	28.90%	30.70%
Debt-free Net Working Capital to Revenue	46.39%	48.77%	54.66%	54.69%	53.84%	53.59%	53.05%	51.63%	54.46%	54.55%	58.14%
Net Working Capital to Revenue	45.02%	47.38%	53.24%	53.30%	52.49%	51.02%	50.77%	49.34%	52.01%	51.93%	55.19%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.77	$1.34	$0.92	$0.34	$0.22	($1.02)	$0.59	($26.47)	($0.64)	$0.57	$0.09
Adjusted Weighted Average Basic Shares Outstanding	67.40M	67.30M	67.40M	67.30M	67M	66.80M	66.90M	66.80M	66.70M	59.70M	61M
Adjusted Diluted Earnings per Share	$0.77	$1.34	$0.92	$0.33	$0.22	($1.01)	$0.58	($26.47)	($0.64)	$0.58	$0.09
Adjusted Weighted Average Diluted Shares Outstanding	67.70M	67.60M	67.60M	67.50M	67.40M	66.80M	67.10M	66.80M	66.70M	59.90M	61.10M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	67.07M	67.38M	67.30M	67.29M	67.20M	67.06M	66.88M	66.86M	66.77M	66.67M	66.51M
Normalized Net Operating Profit after Tax (NOPAT)	112	98	92	92	87	75	84	103	5.60	142	108
Normalized NOPAT Margin	11.96%	10.48%	10.31%	10.34%	10.00%	8.39%	9.01%	10.26%	0.71%	13.11%	11.30%
Pre Tax Income Margin	6.30%	8.45%	6.70%	2.48%	2.19%	-8.96%	2.36%	-178.56%	-9.95%	6.08%	4.19%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.00	2.27	1.78	1.15	1.14	0.12	1.19	-19.40	0.04	1.76	1.49
NOPAT to Interest Expense	1.75	2.65	1.92	1.13	0.87	0.16	2.25	-13.49	0.01	1.59	0.22
EBIT Less CapEx to Interest Expense	1.68	1.41	1.46	0.92	0.95	-0.22	1.02	-19.59	-0.16	1.13	1.16
NOPAT Less CapEx to Interest Expense	1.43	1.78	1.60	0.91	0.68	-0.18	2.08	-13.68	-0.19	0.96	-0.10
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	25.99%	31.05%	190.32%	750.00%	-3.31%	-3.20%	-3.43%	-3.26%	37.16%	15.62%	11.16%
Augmented Payout Ratio	25.99%	31.05%	190.32%	750.00%	-3.31%	-3.20%	-3.43%	-3.26%	37.16%	15.62%	11.16%

Frequently Asked Questions About MKS Instruments' Financials

When does MKS Instruments's financial year end?

According to the most recent income statement we have on file, MKS Instruments' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has MKS Instruments' net income changed over the last 9 years?

MKS Instruments' net income appears to be on a downward trend, with a most recent value of $190 million in 2024, rising from $122.30 million in 2015. The previous period was -$1.84 billion in 2023. See where experts think MKS Instruments is headed by visiting MKS Instruments' forecast page.

What is MKS Instruments's operating income?

MKS Instruments's total operating income in 2024 was $498 million, based on the following breakdown:

Total Gross Profit: $1.71 billion
Total Operating Expenses: $1.21 billion

How has MKS Instruments revenue changed over the last 9 years?

Over the last 9 years, MKS Instruments' total revenue changed from $813.52 million in 2015 to $3.59 billion in 2024, a change of 340.8%.

How much debt does MKS Instruments have?

MKS Instruments' total liabilities were at $6.27 billion at the end of 2024, a 5.7% decrease from 2023, and a 5,473.2% increase since 2015.

How much cash does MKS Instruments have?

In the past 9 years, MKS Instruments' cash and equivalents has ranged from $227.57 million in 2015 to $966 million in 2021, and is currently $714 million as of their latest financial filing in 2024.

How has MKS Instruments' book value per share changed over the last 9 years?

Over the last 9 years, MKS Instruments' book value per share changed from 21.80 in 2015 to 34.50 in 2024, a change of 58.3%.

Related Companies

This page (NASDAQ:MKSI) was last updated on 5/27/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MKS Instruments (MKSI) Financials

Frequently Asked Questions About MKS Instruments' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

MKS Instruments (MKSI) Financials

Annual Income Statements for MKS Instruments

Quarterly Income Statements for MKS Instruments

Annual Cash Flow Statements for MKS Instruments

Quarterly Cash Flow Statements for MKS Instruments

Annual Balance Sheets for MKS Instruments

Quarterly Balance Sheets for MKS Instruments

Annual Metrics And Ratios for MKS Instruments

Quarterly Metrics And Ratios for MKS Instruments

Frequently Asked Questions About MKS Instruments' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools